Statistics for BioLargo, (id:11360 BLGO)

Valuation metrics

Market cap

54.11M

Enterprise value

53.73M

Trailing P/E (ttm)

-9.00

Forward P/E

-21.50

PEG ratio

Price/Sales (ttm)

3.40

Price/Book (mrq)

7.83

Enterprise Value/Revenue

3.07

Enterprise Value/EBITDA

-14.22

Overview

Shares outstanding

300.62M

Float

258.54M

Shares short

% Held by insiders

0.14%

% Held by institutions

0.00%

Average volume (10 days)

418.82K

Average volume (90 days)

Price summary

52-Week low

0.16

52-Week high

0.45

52-Week change

5.50%

Beta

0.20

50-Day moving average

0.23

200-Day moving average

0.28

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

May 28th, 1997

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-28.09%

Return on equity

-81.54%

Income statement

Revenue (ttm)

0.04

Revenue per share (ttm)

0.04

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

0.00

Diluted EPS (ttm)

-0.02

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

0.00

Total cash per share (mrq)

0.02

Total debt (mrq)

1.55M

Total Debt/Equity (mrq)

0.26

Current ratio (mrq)

236.06%

Book value per share (mrq)

0.02

Cash flow

Cash flow statement

-3,366,000.00

Levered free cash flow (LFCF)

1.44M